The United Kingdom's stock market has recently experienced declines, influenced by disappointing trade data from China and its broader economic challenges. Amidst these market conditions, identifying undervalued stocks can offer investors potential opportunities for value in a landscape marked by global uncertainties. In this environment, a good stock may be characterized by robust fundamentals such as strong balance sheets and consistent earnings, which provide resilience against ongoing market volatilities. Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom Name Current Price Fair Value (Est) Discount (Est) Begbies Traynor Group (AIM:BEG) £1.01 £1.98 48.9% Gaming Realms (AIM:GMR) £0.3655 £0.69 46.9% WPP (LSE:WPP) £7.414 £14.28 48.1% Calnex Solutions (AIM:CLX) £0.49 £0.98 49.8% LSL Property Services (LSE:LSL) £3.35 £6.33 47.1% Ibstock (LSE:IBST) £1.82 £3.41 46.5% Auction Technology Group (LSE:ATG) £4.855 £9.69 49.9% Accsys Technologies (AIM:AXS) £0.552 £1.06 47.8% Entain (LSE:ENT) £6.452 £12.34 47.7% Nexxen International (AIM:NEXN) £2.475 £4.82 48.6% Click here to see the full list of 61 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. LBG Media Overview: LBG Media plc is an online media publisher operating in the United Kingdom, Ireland, Australia, the United States, and internationally, with a market capitalization of approximately £247.76 million. Operations: The company generates £67.51 million in revenue from its online media publishing operations. Estimated Discount To Fair Value: 20.5% LBG Media, priced at £1.19, is currently valued below its estimated fair value of £1.49, indicating a potential undervaluation by over 20%. Despite this, the company shows promising growth prospects with earnings expected to increase by 43.84% annually. However, it's important to note that LBG's return on equity is anticipated to be modest at 16.1% in three years' time and recent financial results have been affected by significant one-off items. Revenue growth projections also outpace the UK market average significantly at 11.7% per year. Insights from our recent growth report point to a promising forecast for LBG Media's business outlook. Click to explore a detailed breakdown of our findings in LBG Media's balance sheet health report. AIM:LBG Discounted Cash Flow as at Jul 2024 AstraZeneca Overview: AstraZeneca PLC is a biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of prescription medicines, with a market capitalization of approximately £189.35 billion. Operations: The company generates its revenue primarily from the biopharmaceuticals segment, which amounted to $47.61 billion. Estimated Discount To Fair Value: 42% AstraZeneca, a prominent pharmaceutical firm, showcased robust financial performance in its recent earnings report. For Q2 2024, the company reported significant year-over-year increases in sales to US$482 million and net income to US$1.927 billion. This growth is supported by strategic product launches and regulatory approvals, such as Voydeya for PNH treatment in Canada, enhancing its revenue streams from high-margin products. Despite these strengths, investors should consider the inherent risks of drug development and market competition that could impact future cash flows. The growth report we've compiled suggests that AstraZeneca's future prospects could be on the up. Take a closer look at AstraZeneca's balance sheet health here in our report. LSE:AZN Discounted Cash Flow as at Jul 2024 Informa Overview: Informa plc is a global company based in the UK, specializing in international events, digital services, and academic research, with a market capitalization of approximately £11.60 billion. Operations: The company's revenue is divided into four key segments: Informa Tech generates £426.70 million, Informa Connect brings in £630.20 million, Informa Markets contributes £1.67 billion, and Taylor & Francis accounts for £636.70 million in revenues. Estimated Discount To Fair Value: 42.3% Informa is currently trading at £8.78, significantly below its estimated fair value of £15.23, indicating a potential undervaluation based on discounted cash flow analysis. Despite this, the company's recent half-year earnings report showed a decline in net income to £147.3 million from £253.5 million year-over-year, with basic earnings per share also decreasing. However, Informa's revenue is expected to grow faster than the UK market average, with forecasts predicting significant earnings growth over the next three years and an unstable dividend track record that may concern some investors. Our comprehensive growth report raises the possibility that Informa is poised for substantial financial growth. Click here to discover the nuances of Informa with our detailed financial health report. LSE:INF Discounted Cash Flow as at Jul 2024 Next Steps Click here to access our complete index of 61 Undervalued UK Stocks Based On Cash Flows. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Curious About Other Options? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:LBG LSE:AZN and LSE:INF. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
Top 3 UK Stocks Estimated To Be Undervalued In July 2024
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...